Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Idera stock drops on hepatitis-C drug delay

April 26, 2011 6:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Idera Pharmaceuticals Inc.'s stock dropped more than 5 percent Monday, following the company's announcement that it would delay the launch of a clinical trial on its drug candidate for hepatitis C.

Reportlinker Adds Epidemiology: Sepsis

April 26, 2011 4:37 am | by Bio-Medicine.Org | News | Comments

NEW YORK, April 26, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Epidemiology: Sepsis http://www.reportlinker.com/p0484945/Epidemiology-Sepsis.html Severe sepsis is a prominent infectious syndrome in the seven major markets,...

Accuray Incorporated Announces HSR Clearance in Acquisition of TomoTherapy

April 26, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., April 26, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, today announced the expiration of the mandatory, pre-merger waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, in connection with the...

Advertisement

Reportlinker Adds Epidemiology: Rheumatoid Arthritis

April 26, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, April 26, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Epidemiology: Rheumatoid Arthritis http://www.reportlinker.com/p0484919/Epidemiology-Rheumatoid-Arthritis.html Globally, between 0.2% and 1.2% of the world population...

LATEST Medical Introduces New Kind of Patient Information Web Site - LATESTBreastCancer.com

April 26, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., April 26, 2011 /- LATEST Medical today launched the first ever Web site that gives cancer patients personalized information about new treatment advances.  The site, LATESTBreastCancer.com, empowers breast cancer patients to participate in treatment decisions by...

Neusoft to Invest in Israeli Medical Solutions Company for Accelerating Expansion in Global Healthcare Service Market

April 26, 2011 1:36 am | by Bio-Medicine.Org | News | Comments

SHENYANG, China, April 26, 2011 /PRNewswire-Asia/ -- Neusoft Corporation ("Neusoft", 600718.SH), a leading IT solution and service provider in China, recently announced that its wholly-owned subsidiary Neusoft Europe Inc. ("Neusoft Europe") has signed a subscription agreement with Aerotel...

Racial differences in willingness to exhaust personal finances for life-sustaining care

April 25, 2011 8:35 pm | by EurekAlert | News | Comments

(Wiley-Blackwell) Minority races -- especially blacks -- are more willing than whites to expend personal financial resources to prolong life after being diagnosed with lung or colorectal cancer, even if it means using up all of their personal financial resources. That is the conclusion of...

Blacks more willing to exhaust financial resources for more cancer care

April 25, 2011 8:34 pm | by EurekAlert | News | Comments

(University of Alabama at Birmingham) Blacks, Hispanics and Asians are more likely than whites to spend their life savings to extend life; preferences could inform cancer care

Advertisement

Xcovery Vision Founders to Speak at ARVO 2011

April 25, 2011 12:37 pm | by Bio-Medicine.Org | News | Comments

WEST PALM BEACH, Fla., April 25, 2011 /- The ophthalmic therapeutics company Xcovery Vision announced today that Sheridan G. Snyder, OBE, Chairman and CEO, and Dr. Ken Mandell, President and COO, will be speaking at The Association for Research in Vision and Ophthalmology (ARVO) Annual...

Fisher Center Scientists Show That Anti-Inflammatory Drugs Reduce Effectiveness of SSRI Antidepressants

April 25, 2011 12:37 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, April 25, 2011 /PRNewswire-USNewswire/ -- Scientists at the Fisher Center for Alzheimer's Disease Research at The Rockefeller University, led by Paul Greengard, Ph.D ., and Jennifer Warner-Schmidt, Ph.D., have shown that anti-inflammatory drugs, which include ibuprofen, aspirin...

New Biopharmaceutical Company to Accelerate Delivery of Vaccines and Protein Therapeutics

April 25, 2011 10:39 am | by Bio-Medicine.Org | News | Comments

BRYAN/COLLEGE STATION, Texas, April 25, 2011 /- Caliber Biotherapeutics, a fully-integrated biopharmaceutical company, announced the opening of the world's largest plant-made pharmaceutical manufacturing facility in Bryan, Texas, with the capability of producing 10-100 million doses of...

Meaningful Use Outcomes will Change Reporting

April 25, 2011 10:35 am | by Diagnostic Imaging | News | Comments

The usual EHR approach won't suffice in the future. You need to be able to get orders electronically and be more responsible to patients with your reporting.

Dominion Diagnostics Celebrates National Medical Laboratory Professionals Week with Rhode Island Elected Officials

April 25, 2011 10:34 am | by Bio-Medicine.Org | News | Comments

NORTH KINGSTOWN, R.I., April 25, 2011 /- On Wednesday, April 27 at 11 a.m., Dominion Diagnostics will host Rhode Island Congressman James R. Langevin, Governor Lincoln Chafee, Lieutenant Governor Elizabeth H. Roberts, and their staffs for a laboratory tour and luncheon at its headquarters...

Advertisement

AACR Opens Nominations for Award Funded by Susan G. Komen for the Cure®

April 25, 2011 10:33 am | by AACR | News | Comments

Tweet PHILADELPHIA - The American Association for Cancer Research announces a call for nominations for the 2011 AACR Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen for the Cure®. The award recognizes a scientist who is no more than 50 years old and who...

Dealing With Stress in Radiology

April 25, 2011 9:35 am | by Diagnostic Imaging | News | Comments

Your least-favorite tech makes a rookie blunder and screws up a study, perhaps, or PACS fails just as you are hit by a quartet of STATs. What do you do with your aggravation?

Consumer Information on: MEL 80? Excimer Laser System - P060004S001

April 25, 2011 8:31 am | by U.S. Food & Drug Administration | News | Comments

The Carl Zeiss Meditec MEL 80? Excimer Laser System is a refractive excimer laser designed for a particular type of surgery called LASIK2 (laser-assisted in situ keratomileusis) to change how the eye bends light (refractive surgery). The laser system...

Summary Information for: MEL 80? Excimer Laser System

April 25, 2011 8:30 am | by U.S. Food & Drug Administration | News | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for MEL 80? Excimer Laser System (P060004S001).

Robotic Couch Provides Extra Degree of Precision for Patients Undergoing Radiation Therapy for Cancer

April 25, 2011 7:36 am | by Bio-Medicine.Org | News | Comments

NEW YORK, April 25, 2011 /- Accuracy in radiation therapy demands careful targeting and patient positioning – precision measured in millimeters. The Farber Center for Radiation Oncology , the first and only freestanding cancer center of its kind in Manhattan, is among the first...

Pharmacists Offer Guidance on Top Over-The-Counter Medications

April 25, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, April 25, 2011 /PRNewswire-USNewswire/ -- The 2010 Pharmacy Today Over-the-Counter Product Survey , conducted by the American Pharmacists Association , reveals pharmacists believe that 81% of consumers purchase the over-the-counter (OTC) product that was recommended by their...

CryoLife Launches BioGlue® Surgical Adhesive in Japan

April 25, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

ATLANTA, April 25, 2011 /- CryoLife, Inc. (NYSE: CRY ), an implantable biological medical device and cardiovascular tissue processing company, today announced that its BioGlue Surgical Adhesive has launched in Japan and is expected to be available in hospitals by late May 2011. BioGlue...

ConvaTec Healthcare Announces 2010 Year-End Earnings Call

April 25, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

SKILLMAN, N.J., April 25, 2011 /- ConvaTec Healthcare today announced that it will report its 2010 year-end earnings on Thursday, April 28, 2011. David Johnson, CEO and George Kegler, CFO will host an analyst and investor call at 9:00 AM EDT live via telephone. Questions and answers will...

Ferring Celebrates Winners of 2010 My Little Miracle Essay Contest During National Infertility Awareness Week

April 25, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., April 25, 2011 /- Celebrating National Infertility Awareness Week, April 24-30, 2011, Ferring Pharmaceuticals Inc. is honoring three lucky families who won its 2010 My Little Miracle Essay Contest for their inspirational stories about overcoming their struggle with...

Mylan Launches First Generic Version of Femara® Tablets

April 25, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, April 25, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Letrozole Tablets USP, 2.5 mg, under a previously announced settlement and license agreement with Novartis. Mylan was the first company to have filed a...

Thomas Mac Mahon Joins SynapDx Corporation's Board of Directors

April 25, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

SOUTHBOROUGH, Mass., April 25, 2011 /- SynapDx Corporation announced today that Thomas Mac Mahon has joined its board of directors. Thomas Mac Mahon was President and Chief Executive Officer and a member of the Executive and Management Committees of Laboratory Corporation of America...

Volcano Corporation Schedules First Quarter Conference Call, Webcast

April 25, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, April 25, 2011 /- Volcano Corporation (NASDAQ: VOLC ), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that it will report its...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading